← Insider buys
MCRB

Seres Therapeutics, Inc. · Healthcare

President and CEO Roger Pomerantz sold $294K of Seres Therapeutics, Inc.

Sold$294,030
$30.00Price
9,801Shares
−5%Stake

What MCRB did after the filing

Prices for MCRB after this filing aren't in yet.

Traded Tue, May 24. Filed Wed, May 25, 9:11 PM ET, after the close. Not investment advice.